0020

Wanbangde Pharmaceutical Co., Ltd. (002082)

Market Closed
4 Jun, 06:57
XSHE XSHE
¥
7. 58
+0.69
+10.01%
¥
4.56B Market Cap
- P/E Ratio
0.8% Div Yield
106,736,146 Volume
- Eps
¥ 6.89
Previous Close
Day Range
5.69 7.58
Year Range
3.9 7.78

Summary

002082 closed Wednesday higher at ¥7.58, an increase of 10.01% from Tuesday's close, completing a monthly increase of 34.88% or ¥1.96. Over the past 12 months, 002082 stock gained 18.07%.
002082 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.02%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 002082 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

002082 Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Wanbangde Pharmaceutical Co., Ltd. Dividends

0020
002082 10 months ago
Other
¥0.08 Per Share
0020
002082 5 Jun 2023
Other
¥0.12 Per Share
0020
002082 31 May 2021
Other
¥0.2 Per Share
0020
002082 22 Jul 2020
Other
¥0.15 Per Share
0020
002082 12 May 2017
Other
¥0.25 Per Share

Wanbangde Pharmaceutical Co., Ltd. Earnings

16 May 2025 Date
-
Cons. EPS
0.02
EPS
25 Apr 2024 Date
-
Cons. EPS
-
EPS
26 Oct 2023 Date
-
Cons. EPS
-
EPS
26 Oct 2016 Date
-
Cons. EPS
0.08
EPS
24 Aug 2016 Date
-
Cons. EPS
0.12
EPS
0020
002082 10 months ago
Other
¥0.08 Per Share
0020
002082 5 Jun 2023
Other
¥0.12 Per Share
0020
002082 31 May 2021
Other
¥0.2 Per Share
0020
002082 22 Jul 2020
Other
¥0.15 Per Share
0020
002082 12 May 2017
Other
¥0.25 Per Share
16 May 2025 Date
-
Cons. EPS
0.02
EPS
25 Apr 2024 Date
-
Cons. EPS
-
EPS
26 Oct 2023 Date
-
Cons. EPS
-
EPS
26 Oct 2016 Date
-
Cons. EPS
0.08
EPS
24 Aug 2016 Date
-
Cons. EPS
0.12
EPS

Wanbangde Pharmaceutical Co., Ltd. (002082) FAQ

What is the stock price today?

The current price is ¥7.58.

On which exchange is it traded?

Wanbangde Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002082.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.56B.

Has Wanbangde Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Wanbangde Pharmaceutical Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Shouming Zhao CEO
XSHE Exchange
CNE000001P94 ISIN
CN Country
1,499 Employees
- Last Dividend
10 Jun 2008 Last Split
20 Nov 2006 IPO Date

Overview

Wanbangde Pharmaceutical Holding Group Co., Ltd., originally established in 1985 and headquartered in Taizhou City, China, has significantly evolved over the years. Initially known as Wanbangde New Building Materials Co., Ltd., the company underwent a notable transformation in April 2020 when it redirected its focus towards the pharmaceutical industry, consequently changing its name to better reflect its new orientation. Today, it is recognized for its comprehensive involvement in the research and development, production, and sale of various pharmaceutical products and medical equipment not just within China but on an international scale. The company’s operations are segmented into two main areas: Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale, catering to a broad spectrum of healthcare needs from medication to sophisticated medical devices.

Products and Services

Wanbangde Pharmaceutical Holding Group Co., Ltd. offers a wide range of products and services aimed at enhancing healthcare outcomes. These include:

  • Pharmaceutical Products: The company prides itself on a diverse drug portfolio designed to treat a variety of ailments. Some of its key focus areas include cardiovascular and cerebrovascular diseases, as well as conditions affecting the nervous, respiratory, mental, and digestive systems. This extensive range demonstrates the company's commitment to addressing multifaceted health challenges.
  • Medical Devices: In addition to pharmaceuticals, the company has developed a noteworthy line of medical devices. This includes orthopedic implant devices such as thoracolumbar fusion, cervical fusion, and spinal internal fixation systems. Independent fusion devices and unicompartmental knee joints are also part of its innovative product offering. These devices play a crucial role in supporting patient recovery and improving quality of life.
  • Medical Equipment and Consumables: Beyond implants, Wanbangde Pharmaceutical is dedicated to supplying essential medical equipment and disposable sterile medical polymer consumables. These cover a wide array of healthcare needs, ensuring that medical professionals are well-equipped to provide care.
  • Protective Equipment: Recognizing the importance of safety in healthcare settings, the company also manufactures protective equipment designed to safeguard both medical personnel and patients alike. This line of products is crucial, especially in contexts requiring stringent infection control measures.
  • Hospital Engineering Services: Extending beyond tangible products, Wanbangde Pharmaceutical offers hospital engineering services, contributing to the design and construction of healthcare facilities. This comprehensive approach facilitates the creation of functional and efficient medical spaces, optimizing the delivery of care.

Contact Information

Address: No. 28, Baizhang North Road, Taizhou City, China, 317500
Phone: 86 57 6861 83999